18
total announcements
INDOUS.NS · 15 min delayed
Indo Us Biotech Limited
Indo Us Biotech Limited has informed the Exchange regarding Intimation of Book Closure for the purpose of 22nd AGM pursuant to Regulation 42 of SEBI (LODR)
Indo Us Biotech Limited
Indo Us Biotech Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
Indo Us Biotech Limited
Indo Us Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026, where the Board met and resolved various agendas including calling of Annual General Meeting, approved draft notice and directors' report, and appointment of statutory auditors.
Indo Us Biotech Limited
Indo Us Biotech Limited has announced the publication of unaudited quarterly financial results for the quarter ended June 30, 2026, as per Regulation 47 of SEBI LODR Regulations.
Indo Us Biotech Limited
Indo US Bio-Tech Limited has submitted its standalone unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results and the Statutory Auditors providing a limited review report.
Indo Us Biotech Limited
Indo Us Biotech Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results and limited review reports from the Auditor.
Indo Us Biotech Limited
Indo Us Biotech Limited has informed the Exchange regarding Proceedings of Postal Ballot. The company has engaged the services of National Securities Depository Limited (NSDL) to provide remote e-voting facility to the Members of the Company. The proposed resolution and the explanatory statement are annexed hereto. The result of the Postal Ballot shall be declared by the Chairman or any other duly authorized person of the Company on or before Wednesday, 5th August, 2026.
Indo Us Biotech Limited
Indo Us Biotech Limited has submitted a scrutinizer's report of a postal ballot and informed the exchange about the voting results of the shareholders meeting.
Indo Us Biotech Limited
Indo Us Biotech Limited has submitted a compliance certificate for the quarter ended 30-06-2026, stating that they have a Structured Digital Database (SDD) in place, but have faced a technical issue resulting in the non-availability of historical SDD records. The company has taken corrective and preventive measures to strengthen internal controls and ensure compliance with SEBI regulations.
Indo Us Biotech Limited
Indo Us Biotech Limited has informed the Exchange about Revised Outcome of the Board Meeting held on 10 July 2026, reconstituting committees with effective date from 21st April 2026.
Indo Us Biotech Limited
Indo Us Biotech Limited has informed the Exchange about the resignation of its statutory auditor, M/s. Gautam N Associates, and the appointment of M/s. Bhagat & Associates as the new statutory auditor.
Indo Us Biotech Limited
Indo Us Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on July 10, 2026. The company has approved changes in the composition of its committees, including the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee.
Indo Us Biotech Limited
Indo Us Biotech Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming no securities were received for dematerialization up to June 30, 2026.
Indo Us Biotech Limited
Jagdishkumar Devjibhai Ajudiya, a promoter of Indo Us Biotech Limited, has submitted a disclosure under SEBI Takeover Regulations, stating that he held 68.29% of the company's shares as of March 31, 2026, and has not made any encumbrance of shares during the financial year.
Indo Us Biotech Limited
Indo Us Biotech Limited has informed the Exchange about the completion of dispatch of the Notice of Postal Ballot and publication of newspaper advertisement.
Indo Us Biotech Limited
Indo Us Biotech Limited has informed the Exchange regarding Notice of Postal Ballot, where the company proposes to obtain the consent of the shareholders by way of Postal Ballot for the matters as considered in the Resolution appended below.
Indo Us Biotech Limited
Indo Us Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on July 03, 2026. The Board of Directors has decided to seek consent of the Members of the Company by way of Special Resolution through Postal Ballot process for Regularization of appointment of Mrs. Hemanshi Darsh Soni as an Non Executive Independent Director of the Company for a term of five consecutive years. The Board has also approved the appointment of M/s. Bhagat & Associates, Chartered Accountants as Statutory Auditors of the Company with effect from 16 June 2026, subject to approval of the shareholders of the Company.
Indo Us Biotech Limited
Indo Us Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.